France Battles Mediterranean Wildfires as Heatwave Fuels Fire Risk 
Gold Price Hits Two-Month High as Investors Await US Inflation Data 
Gold Prices Hold Near Seven-Week High as Markets Await U.S. Inflation Data 
Brazil Supreme Court Tightens Jair Bolsonaro House Arrest Ahead of Election 
US-Backed Pediatric HIV Treatment Drops After Foreign Aid Changes, Study Finds 
Paramount-Warner Bros. Merger Delayed Until 2027 Amid Antitrust Lawsuit 
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users 
South Korean Won Leads Asian FX Losses as Dollar Rises 
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 
Eduardo Bolsonaro Granted U.S. Green Card Amid Brazil Legal Battle and Tariff Dispute 
Treasury Wine Estates Shares Jump as U.S. Overhaul Lifts FY2026 Outlook 
France Keeps Top Health Alert as Officials Brace for Another Heatwave 
Appeals Court Rejects Trump Bid to Reinstate $100,000 H-1B Visa Fee 
Mercedes-Benz Stock Offers Deep-Value Potential as Citi Sees Recovery Catalysts 
UNAIDS Urges U.S. to Reconsider South Africa HIV Funding Withdrawal 
Airbus Joins Air India A320 Altitude Drop Probe 
Johnson & Johnson (J&J) has sued drug distributors and a pharmacy seeking to stop the sale of counterfeit versions of its HIV drugs, and at least $25 million in damages from each defendant.
Patients complaining about receiving the wrong pills in their prescription bottles led J&J to discover widespread counterfeiting, as did the voluntary return of hundreds of bottles of counterfeit pharmaceuticals from one of the defendants, distributor ProPharma Distribution LLC.
Following Gilead Sciences Inc.'s lawsuit in January, the firm said it became aware of the sale of counterfeit versions of its HIV medications. Symtuza, a multi-drug combination treatment, as well as Prezcobix, Prezista, and Edurant, are among the medications at issue.
J&J claims that counterfeit bottles occasionally included a different HIV medicine than what was advertised on the label and that one counterfeit bottle contained the strong antipsychotic Seroquel.
The defendants include ProPharma, Safe Chain Solutions LLC, and Scripts Wholesale Inc, as well as drugstore operator I Care Pharmacy 14 and the business' individual proprietors.
According to the lawsuit, I Care Pharmacy had a physical location in New York City that was closed down immediately after a fraudulent transaction was found.
J&J believes the pharmacy is linked to a criminal counterfeiting network that is still operational in New York City, dispensing hazardous counterfeit HIV medication.
